McKesson Corporation

NYSE:MCK

Medical - Distribution

Healthcare
$1,084.43 -3.71%

-$28.96 today

Market cap
$125.21B
Beta
0.32
P/E (TTM)
19.3
EPS (TTM)
$39.00
Dividend yield
0.44%
52W Low $637.00High $999.00

Volume 0.67M

Average 1.03M

MCK Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

McKesson CorporationNYSE: MCK

Net Receivables · Q1 FY2027 · quarter ended Jun 2026

Net receivables rises 7.7% from a year ago

Net receivables stood at $30.32B at the end of Q1 FY2027, up 7.7% from a year earlier and up 8.3% from the prior quarter. Over 3 fiscal years it compounded at +13.0% a year.

Context

  • Net receivables amounted to 34.3% of total assets at the end of Q1 FY2027, down 0.3 pp from a year earlier.
  • Net receivables increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +7.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$30.32B+8.3% QoQ
Last fiscal yearMar 2026
$27.99B+9.1% YoY
Year agoJun 2025
$28.16B+7.7% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.7%——
1 year+9.1%——
3-year CAGR+13.0%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2026
27.99B USD
Year-over-year change
+9.1%
4-year CAGR
+10.8%

Net Receivables vs competitors

How MCK compares with its peers on the latest reported figures

  • MCK's Jun 2026 net receivables of $30.32B is the highest of the 4 companies compared; the peer median is $14.54B.
  • Its year-over-year change of +7.7% is the highest of 4, against a peer median of +3.6%.
  • Net receivables amounts to 34.3% of total assets for MCK, versus a peer median of 24.4%.
MCK Competitors Peer median
Net Receivables for MCK and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MCKMcKesson CorporationJun 2026$30.32B +7.7%+13.0%34.3%
CORCencora, Inc.Jun 2026$25.45B +3.6%+10.6%30.4%
CAHCardinal Health, Inc.Sep 2026$14.54B +5.6%+7.5%24.4%
ACHAccendra Health, Inc.Mar 2026$103.7M -82.1%-49.9%4.3%
Peer median (excluding MCK) $14.54B+3.6%+7.5%24.4%

Competitors are the stored peer set for MCK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Cash & Equivalents3.53B4.68B4.58B5.69B3.98B
Short-term Investments00000
Net Receivables18.58B19.41B21.62B25.64B27.99B
Inventory18.7B19.69B21.14B23B24.21B
Other Current Assets4.52B513M626M1.06B1.04B
Total Current Assets46.23B44.29B47.97B55.4B57.21B
Property, Plant & Equipment (Net)3.64B3.81B4.05B4.28B4.73B
Goodwill9.45B9.95B10.13B10.02B11.32B
Intangible Assets2.06B2.28B2.11B1.46B4.08B
Long-term Investments0312M348M0267M
Tax Assets0(312M)000
Other Non-current Assets1.92B1.99B2.84B3.97B4.73B
Total Non-current Assets17.07B18.03B19.47B19.74B25.11B
Total Assets63.3B62.32B67.44B75.14B82.32B
Account Payables38.09B42.49B47.1B55.33B59.97B
Short-term Debt799M968M50M1.19B1.27B
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities4.74B0000
Total Current Liabilities48.47B47.96B52.36B61.6B67.02B
Long-term Debt5.08B4.63B5.58B4.46B5.11B
Deferred Tax Liabilities1.42B1.39B917M1.03B1.33B
Deferred Revenue (Non-current)00000
Other Non-current Liabilities8.76B8.44B8.72B8.26B7.75B
Total Non-current Liabilities16.62B15.85B16.69B15.23B16.14B
Total Liabilities65.09B63.81B69.04B76.83B83.16B
Common Stock2M3M3M3M3M
Retained Earnings9.03B12.3B14.98B17.92B22.29B
Accumulated OCI(1.53B)(905M)(881M)(932M)(1.45B)
Other Stockholders Equity0000708M
Minority Interest480M367M372M380M1.34B
Total Equity(1.79B)(1.49B)(1.6B)(1.69B)(834M)
Total Debt7.54B7.3B7.39B7.39B8.61B
Net Debt4.01B2.62B2.81B1.7B4.64B

McKesson Corporation

NYSE:MCK

Intrinsic Alpha fair value

Locked

Current Price

$1,084.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.